[1] Liu T,Liu M,Dai Y. γεT Cell is impacted to erythropoies suppression in patient with acquired pure red cell aplastic anemia. Blood, 2004,13b
[2] Liu T, Xu F, Zhu HL. Analysis of T cell subets and CD3S chain expression in myelodysplastic syndromes patients. Blood, 2003,102(11)
[3] Niu T,Wei YQ, Liu T.Construction of a recombinant protein vaccine based on xenopus homologous vascular endothelial growth factor(VEGF) and its antitumor efficacy. Blood, 2002,100(11)
[4] Gong YP, Liu T, Jia YQ.Comparison of Pgp- and MRP-mediated multidrug resistance in leukemia cell lines. Int J Hematol, 2002,75(2)
[5] Yang YM, Liu T. Study on anti-leukemia effect of tanshinone IIA in vitro and in vivo to acute promyelocytic leukemia. Blood, 2000,94(10)
[6] Liu T, Jia YQ. Hematopoietic chimerism and clinical outcome after allogeneic peripheral blood stem cell transplantation with MMC conditioning regimen. Blood, 2000,94(10)
[7] Liu T. MMC conditioning regimen (melphalan, MeCCNU and cyclophos phamide) followed by allogeneic peripheral blood stem cells transplantation for chronic myeloid leukemia. Blood, 1998,92(10)
[8] 鄒文蓉,劉霆,孟文彤,余江,牛挺.
骨髓增生異常綜合征患者骨髓血管新生的初步觀察.
四川大學(xué)學(xué)報（醫(yī)學(xué)版), 2005,36(1)
[9] 劉霆,李建軍,賈永前,徐才剛,向兵.異基因造血干細胞移植治療
白血病臨床總結(jié).四川醫(yī)學(xué), 2004,25(3)
[10] 孟文彤,劉霆,李建軍,史青,向兵.初發(fā)慢性髓系白血病bcr/abl融合基因轉(zhuǎn)錄子與臨床關(guān)系的觀察.四川醫(yī)學(xué), 2004,25(3)
[11] 譚競,劉霆.
多發(fā)性骨髓瘤的非細胞毒性治療的基礎(chǔ)和臨床研究進展.四川醫(yī)學(xué), 2004,25(6)
[12] 李建軍,劉霆,吳謹緒.骨髓增生異常綜合征發(fā)病機制及治療的研究進展.四川醫(yī)學(xué), 2004,25(3)
[13] 許芳,劉霆,朱煥玲,崔旭
gydjdsj.org.cn,徐才剛.骨髓增生異常綜合征患者T細胞亞型和CD3zeta 表達的分析.
中國實驗血液學(xué)雜志, 2004,12(6)
[14] 代陽,劉霆,朱煥玲,崔旭,徐才剛.獲得性純紅再障患者外周血T細胞亞群分析.四川醫(yī)學(xué), 2004,25(3)
[15] 劉霆,吳謹緒.我省
血液病學(xué)發(fā)展應(yīng)重視普及與提高相結(jié)合.四川醫(yī)學(xué), 2004,25(3)
[16] 陳心傳,劉霆,崔旭.伊馬替尼治療
慢性粒細胞白血病出現(xiàn)腦
水腫一例.
中華血液學(xué)雜志, 2004,25(7)
[17] 汪宇春,劉霆,張霽.STR-PCR定量分析非清髓性干細胞移植后造血嵌合體.
四川大學(xué)學(xué)報(醫(yī)學(xué)版), 2003,34(3)
[18] 劉霆,廖小梅,黃杰.非清髓性干細胞移植治療骨髓增生異常綜合征二例.
中華內(nèi)科雜志, 2002,41(4)
[19] 劉霆.造血干細胞移植中輸血的特點和應(yīng)用.
中國輸血雜志, 2002,14(5)
[20] 劉霆.造血干細胞移植中輸血的特點和應(yīng)用.中國輸血雜志, 2001,14(5)劉霆.非何杰金
惡性淋巴瘤病理分型及其治療進展.四川醫(yī)學(xué), 2001,22(8)
[21] 劉霆,賈永前,徐才剛.非血緣供者異基因骨髓移植治療慢性粒細胞白血病.華西醫(yī)科大學(xué)學(xué)報, 2000,31(4)
[22] 劉霆,余喜訊,趙長生.聚醚砜中空纖維膜血漿分離器血漿分離功能與血液相容性的評價.
生物醫(yī)學(xué)工程學(xué)雜志, 2000,17(3)
聯(lián)系方式:
電話： 028-85422364 郵箱:Tingliu@mail.sc.cninfo.net
